In this video you can learn why Amanda Veall decided to prescribe a rapid acting insulin biosimilar, how she collaborated with clinical teams to drive the adoption of this biosimilar in her local region and find out how the patient experience has been with this biosimilar.
You can find answers to the following questions:
Min 00:10 - Why did you decide to prescribe a rapid acting insulin biosimilar?
Min 00:32 - Did you have any concerns/fears about using a biosimilar insulin? And if so what did you learn that put your mind at ease?
Min 01:04 - What steps did you take with the patient to initiate/switch to a rapid acting insulin biosimilar?
Min 01:57 - How has been the patient experience (Type 1 and Type 2) in using a rapid acting insulin biosimilar?
Min 02:47 - What practical recommendations can you give to other DSNs to initiate/switch patients to a rapid acting insulin biosimilar?
Download video summary